https://www.selleckchem.com/pr....oducts/b102-parp-hda
Sexual function increased significantly over time in both the topical estrogen therapy (P 0.001) and laser therapy (P 0.001) groups. Subjective evaluation through physical examination showed a significant improvement in atrophy in both the groups. Despite the nonequivalence with topical estrogen therapy, our data suggest that laser therapy is an effective method for the treatment of vulvovaginal atrophy. Despite the nonequivalence with topical estrogen therapy, our data suggest that laser therapy is an effective me